Shares of Advanced Oncotherapy plc (LON:AVO – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.78 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares traded.
Advanced Oncotherapy Stock Down 9.1 %
The company has a quick ratio of 0.13, a current ratio of 1.26 and a debt-to-equity ratio of 98.71. The company’s fifty day moving average is GBX 1.75 and its 200-day moving average is GBX 1.78. The company has a market cap of £9.49 million, a PE ratio of -25.00 and a beta of 0.09.
About Advanced Oncotherapy
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Featured Stories
- Five stocks we like better than Advanced Oncotherapy
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- MarketBeat Week in Review – 4/15 – 4/19
- How Investors Can Find the Best Cheap Dividend Stocks
- Comprehensive Analysis of PayPal Stock
- Using the MarketBeat Dividend Yield Calculator
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
